HN

Huifeng Niu

RA Roche Glycart Ag: 2 patents #32 of 86Top 40%
Hoffmann-La Roche: 1 patents #1,850 of 3,238Top 60%
MP Millennium Pharmaceuticals: 1 patents #496 of 771Top 65%
TL Takeda Pharmaceutical Company Limited: 1 patents #859 of 1,531Top 60%
📍 Scotch Plains, NJ: #158 of 466 inventorsTop 35%
🗺 New Jersey: #16,490 of 69,400 inventorsTop 25%
Overall (All Time): #932,668 of 4,157,543Top 25%
5
Patents All Time

Issued Patents All Time

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
12048699 Cancer treatment methods based on TP53 mutation status and hypermutation Akihiro Ohashi, Kenichi Iwai, Tadahiro Nambu, Kazunori Yamanaka, Kentaro Otake +2 more 2024-07-30
11214622 Antibodies specific for DR5 and methods of use Peter Bruenker, Sherif Daouti, Ningping Feng, Claudia Ferrara Koller, Guy Georges +13 more 2022-01-04
9926379 Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5 Peter Bruenker, Sherif Daouti, Ningping Feng, Claudia Ferrara Koller, Guy Georges +13 more 2018-03-27
9724354 Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinase Rachael L. Brake 2017-08-08
9409961 Cell penetrating peptides to target EIF4E Waleed Danho, Nader Fotouhi, Yi Han, Wajiha Khan, Francesca Milletti 2016-08-09